Gate News message, April 17 — OpenAI unveiled an early-stage version of GPT-Rosalind, an artificial intelligence model designed to accelerate drug discovery and life sciences research, on April 16. The model will initially be available as a research preview to enterprise customers, with early users including pharmaceutical company Amgen, vaccine producer Moderna, and the Allen Institute for Brain Science.
GPT-Rosalind is designed to help researchers extract insights from large datasets and translate scientific findings into patient-focused healthcare applications. Named after biophysicist Rosalind Franklin, the model integrates large language models with specialized biochemical knowledge to support complex scientific reasoning across evidence synthesis, hypothesis generation, and multi-step experimental planning.
OpenAI CEO Sam Altman indicated the company plans to shift its business model beyond subscription fees, moving toward sharing drug development risks with pharmaceutical companies and collecting technology royalties after drug approvals. Following the announcement, stock prices of drug discovery-focused companies declined: IQVIA fell 3.45%, Charles River Laboratories dropped 2%, Recursion Pharmaceuticals fell 4%, and Schrodinger declined nearly 3%.
Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to
Disclaimer.
Related Articles
Meta Stock Rises 1.73% as Company Plans 8,000-Job Layoff Starting May 20
Meta Platforms plans to cut about 8,000 jobs, or 10% of its workforce, starting May 20, despite rising stock prices. The company, with over $200 billion in revenue, is focusing on AI investments amid significant restructuring, aligning with industry trends of layoffs.
GateNews2h ago
Google’s annual report says Gemini achieves millisecond interception, blocking 99% of scam ads
The article discusses how Google strengthens ad safety through its generative AI system, Gemini. The report shows that the speed at which it blocks noncompliant ads has been reduced to milliseconds, with a blocking rate of 99%. Last year, Google removed 8.3 billion ad listings and suspended 24.9 million accounts, indicating a significant rise in the number of scam ads. Experts point out that this is a contest between AI and AI, and that in the future there will still be challenges in dealing with both legal and illegal activities brought about by AI.
ChainNewsAbmedia4h ago
Ethereum Co-founder Lubin: AI Will Be Critical Turning Point for Crypto, But Tech Giant Monopoly Poses Systemic Risk
Ethereum co-founder Joseph Lubin emphasized the transformative potential of AI for the cryptocurrency sector while cautioning against the risks of centralization among tech giants. He envisions AI-driven autonomous transactions on blockchain and highlights the convergence of traditional finance with DeFi.
GateNews6h ago
Elon Musk Pushes 'Universal High Income' Checks as Ultimate Solution for AI Unemployment
Elon Musk advocates for a Universal High Income to combat AI-induced unemployment, envisioning a future with ample goods and zero inflation. In contrast, experts like Sam Altman raise concerns about job loss and propose protective measures for workers.
Coinpedia6h ago
DeepSeek Reportedly Launches First External Fundraising Round, Targets $10B+ Valuation and $300M+
DeepSeek, a Chinese AI startup, is negotiating its first external funding round, aiming for at least $300 million at a $10 billion valuation. Despite previous rejections of investment offers, its fundraising discussions are now reportedly underway.
GateNews7h ago
ChatGPT ads move into Australia and New Zealand: Free and Go users first, paid plans stay ad-free
OpenAI expanded ChatGPT advertising on April 17, 2023 to Australia, New Zealand, and Canada for Free and Go users, with no ads for paid users. This marks the second pathway toward AI commercialization and takes into account business and regulatory risks, where the presence of ads can promote paid conversions.
ChainNewsAbmedia9h ago
